MedPath
FDA Approval

Brimonidine Tartrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 27, 2018
Labeling Type
Human Prescription Drug Label
Brimonidine(2 mg in 1 mg)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

INDOCO REMEDIES LIMITED

Indoco Remedies Limited

915851870

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Brimonidine Tartrate

Product Details

NDC Product Code
14445-400
Application Number
ANDA091691
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
December 27, 2018
Sodium CitrateInactive
Code: 1Q73Q2JULRClass: IACT
WaterInactive
Code: 059QF0KO0RClass: IACT
Benzalkonium ChlorideInactive
Code: F5UM2KM3W7Class: IACT
Sodium ChlorideInactive
Code: 451W47IQ8XClass: IACT
Citric Acid MonohydrateInactive
Code: 2968PHW8QPClass: IACT
Code: 4S9CL2DY2HClass: ACTIBQuantity: 2 mg in 1 mg
Polyvinyl AlcoholInactive
Code: 532B59J990Class: IACT
Hydrochloric acidInactive
Code: QTT17582CBClass: IACT
Sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath